Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 31,743 | 23,631 | 18,653 | 27,619 | 52,570 |
| Gross Profit | 31,743 | 23,631 | 18,653 | 27,619 | 52,570 |
| Operating Expenses | 44,042 | 43,414 | 41,505 | 39,494 | 39,699 |
| Operating Income | -12,299 | -19,783 | -22,852 | -11,875 | 12,871 |
| Other Income | 677 | 1,149 | 1,445 | 1,950 | 2,076 |
| Pre-tax Income | -11,622 | -18,634 | -21,407 | -9,925 | 14,947 |
| Income Tax | -3,294 | 10,707 | -7,142 | -3,920 | 1,504 |
| Net Income Continuous | -8,328 | -29,341 | -14,265 | -6,005 | 13,443 |
| Net Income | $-8,328 | $-29,341 | $-14,265 | $-6,005 | $13,443 |
| EPS Basic Total Ops | -0.41 | -1.48 | -0.71 | -0.30 | 0.68 |
| EPS Basic Continuous Ops | -0.41 | -1.48 | -0.71 | -0.30 | 0.68 |
| EPS Diluted Total Ops | -0.41 | -1.45 | -0.71 | -0.30 | 0.65 |
| EPS Diluted Continuous Ops | -0.41 | -1.45 | -0.71 | -0.30 | 0.65 |
| EBITDA(a) | $-10,997 | $-18,475 | $-21,652 | $-11,009 | $13,445 |